Precision BioSciences logo

Precision BioSciences

DTIL | NASDAQ
Chart Builder DCF Calculator
$7.28
-$0.29 (-3.77%)
At close: Nov 16, 2026, 4:00 PM ET
$7.20
-$0.08 (-1.10%)
After-hours: Nov 16, 2026, 7:30 PM ET
-3.77%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
34
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #683/1021 (Top 67%)

Key Statistics

Market Data

Market Cap $203.37M
1D Range
7.25 7.64
52W Range
3.57 10.60

Valuation (TTM)

PE -5.87
PB 3.93
EV/EBITDA -4.25

Valuation (NTM)

Forward PE N/A
Forward PEG 0.11
Price Target $20.00
Loading financial charts...

Profile

Precision BioSciences, Inc. is a clinical-stage biotechnology firm based in the United States, specializing in the creation of both in vivo gene editing solutions and ex vivo allogeneic CAR T-cell the...

Sector Healthcare
Industry Biotechnology
Employees 67
IPO Date Mar 28, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 3, 2026
EPS
-$0.28
Beat +67.06%
REV
$1.25M
Miss -9.09%
Next Earnings
Mar 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$20.00
Upside
+174.73%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.